Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 163

1.

Evaluation of empirical antibiotherapy for acute community-acquired pneumonia prescribed in emergency departments.

Fraisse T, Fayad G, Jardy C, Sotto A.

Med Mal Infect. 2012 Jan;42(1):5-9. doi: 10.1016/j.medmal.2011.10.019. Epub 2011 Dec 7.

PMID:
22154524
2.

[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].

Roger PM, Risso K, Hyvernat H, Landraud L, Vassallo M, Dellamonica J, de Salvador F, Cua E, Bernardin G.

Med Mal Infect. 2010 Jun;40(6):347-51. doi: 10.1016/j.medmal.2010.01.005. Epub 2010 Feb 20. French.

PMID:
20172672
3.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
4.

[Adherence to antibiotherapy guidelines for acute community-acquired pneumonia in adults, in a teaching hospital].

Martinez JS, Le Falher G, Corne P, Bourdin A, Lequellec A, Delabre JP, Makinson A, Hansel S, Reynes J, Le Moing V.

Med Mal Infect. 2010 Aug;40(8):468-75. doi: 10.1016/j.medmal.2010.01.009. Epub 2010 Feb 18. French.

PMID:
20171030
5.

Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors.

Schouten JA, Hulscher ME, Kullberg BJ, Cox A, Gyssens IC, van der Meer JW, Grol RP.

J Antimicrob Chemother. 2005 Sep;56(3):575-82. Epub 2005 Jul 27.

PMID:
16049096
6.

Impact of a guideline on management of children hospitalized with community-acquired pneumonia.

Newman RE, Hedican EB, Herigon JC, Williams DD, Williams AR, Newland JG.

Pediatrics. 2012 Mar;129(3):e597-604. doi: 10.1542/peds.2011-1533. Epub 2012 Feb 20.

PMID:
22351891
7.

Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.

Ye X, Sikirica V, Schein JR, Grant R, Zarotsky V, Doshi D, Benson CJ, Riedel AA.

Clin Ther. 2008 Feb;30(2):358-71. doi: 10.1016/j.clinthera.2008.01.023.

PMID:
18343274
9.

Antibiotic strategy in severe community-acquired pneumococcal pneumonia.

Le Bris-Tomczak A, Bedos JP, Billon C, Samdjee F, Le Monnier A.

Med Mal Infect. 2012 May;42(5):226-34. doi: 10.1016/j.medmal.2012.04.001. Epub 2012 May 12.

PMID:
22583782
10.

[Community-acquired pneumonia].

Blanquer J, Sanz F.

Arch Bronconeumol. 2010 Oct;46 Suppl 7:26-30. doi: 10.1016/S0300-2896(10)70043-0. Review. Spanish.

11.

Empiric management of community-acquired pneumonia in Australian emergency departments.

Maxwell DJ, McIntosh KA, Pulver LK, Easton KL.

Med J Aust. 2005 Nov 21;183(10):520-4.

PMID:
16296965
12.

Role of 'atypical pathogens' among adult hospitalized patients with community-acquired pneumonia.

Lui G, Ip M, Lee N, Rainer TH, Man SY, Cockram CS, Antonio GE, Ng MH, Chan MH, Chau SS, Mak P, Chan PK, Ahuja AT, Sung JJ, Hui DS.

Respirology. 2009 Nov;14(8):1098-105. doi: 10.1111/j.1440-1843.2009.01637.x. Epub 2009 Oct 5.

PMID:
19818051
13.

Prospective, randomised study to compare empirical treatment versus targeted treatment on the basis of the urine antigen results in hospitalised patients with community-acquired pneumonia.

Falguera M, Ruiz-González A, Schoenenberger JA, Touzón C, Gázquez I, Galindo C, Porcel JM.

Thorax. 2010 Feb;65(2):101-6. doi: 10.1136/thx.2009.118588. Epub 2009 Aug 23.

PMID:
19703825
14.

Utility of a pneumonia severity index in the optimization of the diagnostic and therapeutic effort for community-acquired pneumonia.

Ortega L, Sierra M, Domínguez J, Martínez J, Matas L, Bastart F, Galí N, Ausina V.

Scand J Infect Dis. 2005;37(9):657-63.

PMID:
16126566
15.

Selective use of blood cultures in emergency department pneumonia patients.

Benenson RS, Kepner AM, Pyle DN 2nd, Cavanaugh S.

J Emerg Med. 2007 Jul;33(1):1-8. Epub 2007 Jun 18.

PMID:
17630066
16.

Tailored interventions to improve antibiotic use for lower respiratory tract infections in hospitals: a cluster-randomized, controlled trial.

Schouten JA, Hulscher ME, Trap-Liefers J, Akkermans RP, Kullberg BJ, Grol RP, van der Meer JW.

Clin Infect Dis. 2007 Apr 1;44(7):931-41. Epub 2007 Feb 20.

PMID:
17342644
17.

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: a US-based study.

Frei CR, Jaso TC, Mortensen EM, Restrepo MI, Raut MK, Oramasionwu CU, Ruiz AD, Makos BR, Ruiz JL, Attridge RT, Mody SH, Fisher A, Schein JR.

Curr Med Res Opin. 2009 Apr;25(4):859-68. doi: 10.1185/03007990902779749 .

PMID:
19231913
18.

Management in the emergency room of patients requiring hospital treatment of community-acquired pneumonia.

Martínez D, Alvarez Rodríguez V, Ortiz de Zárate MM, Rivas M, Giménez MJ, Aguilar L, Ruiz Polaina MJ, Barberán J, Prieto J; CAPEM Study Group.

Rev Esp Quimioter. 2009 Mar;22(1):4-9.

19.

[Results of survey of adult community-acquired pneumonia utilizing flow chart of diagnostic guideline for management of respiratory infections].

Watanabe A, Matsushima T, Kohno S, Abe S, Aoki N, Kubo K, Sugiyama Y, Kikuchi N, Kudou S, Ishigatsubo Y, Shimokata K, Hirata K, Tohda Y, Narita N, Ueda N, Niki Y, Nasu M, Saitou A.

Nihon Kokyuki Gakkai Zasshi. 2003 Nov;41(11):781-96. Japanese.

PMID:
14661550
20.

Limited usefulness of initial blood cultures in community acquired pneumonia.

Corbo J, Friedman B, Bijur P, Gallagher EJ.

Emerg Med J. 2004 Jul;21(4):446-8.

Supplemental Content

Support Center